Published • loading... • Updated
Moderna (NASDAQ:MRNA) Price Target Raised to $90.00
Summary by thecerbatgem.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Moderna (NASDAQ:MRNA) Price Target Raised to $90.00
Moderna (NASDAQ:MRNA – Free Report) had its price objective hoisted by TD Cowen from $40.00 to $90.00 in a report released on Wednesday morning, MarketBeat.com reports. TD Cowen currently has a hold rating on the stock. Other research analysts have also recently issued research reports about the company. Royal Bank Of Canada reaffirmed a “sector […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
